Table 2.
Association between BRI and CI in different models
| BRI | Crude Model | Model I | Model II | Model III | ||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
| All participants | ||||||||
| Continuous | 1.38 (1.20–1.59) | < 0.001 | 1.20 (1.02–1.42) | 0.032 | 1.17 (0.98–1.38) | 0.075 | 1.17 (0.98–1.39) | 0.078 |
| T1 (2.75–4.52) | Reference | Reference | Reference | reference | ||||
| T2 (4.52–5.19) | 1.47 (1.12–1.93) | 0.005 | 1.37 (1.02–1.82) | 0.034 | 1.35 (1.00–1.80) | 0.047 | 1.34 (1.00–1.81) | 0.051 |
| T3 (5.19–8.28) | 1.84 (1.41–2.41) | < 0.001 | 1.45 (1.06–1.99) | 0.020 | 1.40 (1.02–1.93) | 0.038 | 1.39 (1.00–1.93) | 0.047 |
| P for trend | < 0.001 | 0.020 | 0.039 | 0.048 | ||||
| Male | ||||||||
| Continuous | 1.24 (0.97–1.59) | 0.088 | 1.08 (0.83–1.40) | 0.577 | 1.06 (0.82–1.38) | 0.653 | 1.04 (0.80–1.37) | 0.750 |
| T1 (2.83–4.29) | Reference | Reference | Reference | Reference | ||||
| T2 (4.29–4.81) | 1.39 (0.95–2.04) | 0.086 | 1.36 (0.92–2.01) | 0.126 | 1.38 (0.92–2.05) | 0.116 | 1.38 (0.92–2.07) | 0.117 |
| T3 (4.81–6.61) | 1.62 (1.11–2.37) | 0.012 | 1.35 (0.91–2.00) | 0.139 | 1.31 (0.88–1.95) | 0.188 | 1.27 (0.85–1.91) | 0.244 |
| P for trend | 0.013 | 0.140 | 0.192 | 0.251 | ||||
| Female | ||||||||
| Continuous | 1.46 (1.19–1.80) | < 0.001 | 1.30 (1.05–1.62) | 0.017 | 1.26 (1.00–1.57) | 0.045 | 1.26 (1.01–1.59) | 0.045 |
| T1 (2.75–4.92) | Reference | 0.005 | Reference | Reference | Reference | |||
| T2 (4.92–5.56) | 1.75 (1.19–2.58) | < 0.001 | 1.62 (1.08–2.42) | 0.020 | 1.62 (1.07–2.44) | 0.022 | 1.70 (1.11–2.60) | 0.014 |
| T3 (5.56–8.28) | 2.03 (1.38–2.99) | < 0.001 | 1.70 (1.13–2.55) | 0.011 | 1.58 (1.04–2.40) | 0.031 | 1.64 (1.07–2.51) | 0.023 |
| P for trend | < 0.001 | 0.012 | 0.032 | 0.024 | ||||
Model I: Adjust for age, sex (only for overall population), marital status, education level
Model II: Adjust for diabetes course, diabetic dietary control, and smoking status plus model I
Model III: Adjust for stroke, hypoglycemic events in last 3 months, cardiovascular disease, microangiopathy, GFR, and TC plus model II;